TipRanks

Notifications

Tag: PAYO

Total 148 Posts

Northland העלו את מחיר היעד עבור Payoneer Global (NURAFResearch Report), Payoneer (PAYOResearch Report) and Qualys (QLYSResearch Report).

Nomura Research Institute (NURAF)

In a report released today, Hiroko Sato from Jefferies maintained a Hold rating on Nomura Research Institute, with a price target of Yen5100.00. The company’s shares closed last Tuesday at $30.24.

According to TipRanks.com, Sato is a 3-star analyst with an average return of 7.2% and a 55.6% success rate. Sato covers the Technology sector, focusing on stocks such as GMO Payment Gateway, Trend Micro, and NTT DATA.

The word on The Street in general, suggests a Hold analyst consensus rating for Nomura Research Institute with a $33.37 average price target.

See today’s best-performing stocks on TipRanks >>

Payoneer (PAYO)

Benchmark Co. analyst Mark Palmer maintained a Buy rating on Payoneer today and set a price target of $12.00. The company’s shares closed last Tuesday at $10.30, close to its 52-week high of $10.35.

Palmer has an average return of 44.2% when recommending Payoneer.

According to TipRanks.com, Palmer is ranked #557 out of 9137 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Payoneer with a $10.50 average price target, which is a 12.7% upside from current levels. In a report released yesterday, Northland Securities also maintained a Buy rating on the stock with a $10.00 price target.

Qualys (QLYS)

J.P. Morgan analyst Brian Essex maintained a Sell rating on Qualys today and set a price target of $126.00. The company’s shares closed last Tuesday at $128.23, close to its 52-week low of $119.17.

According to TipRanks.com, Essex is a 4-star analyst with an average return of 10.6% and a 56.4% success rate. Essex covers the Technology sector, focusing on stocks such as International Business Machines, CrowdStrike Holdings, and Palo Alto Networks.

Qualys has an analyst consensus of Hold, with a price target consensus of $141.71, implying a 13.6% upside from current levels. In a report issued on October 23, Morgan Stanley also maintained a Sell rating on the stock with a $123.00 price target.

Read More on NURAF: